U.S., Feb. 4 -- An application to own the trademark for 'BUBBLE POPS' has been filed on Dec. 11, 2025. Owner(s): Cepia LLC; 11701 Borman Drive, Suite 315, MISSOURI Goods and/or Services: For: Coll... Read More
U.S., Feb. 4 -- An application to own the trademark for 'HOT DOG AND SOUR CAT' has been filed on Dec. 11, 2025. Owner(s): Hot Dog and Sour Cat, Inc.; 25 West Highland Ave, Right Hand Suite, NEW JERS... Read More
U.S., Feb. 4 -- An application to own the trademark for 'DHMAKER' has been filed on Dec. 04, 2025. Owner(s): Wei Wang; Room 201, No. 2, Lane 17, Yuanding Road, Yuelong Street, Ninghai County, CHINA ... Read More
WASHINGTON, Feb. 4 -- Sen. Ruben Gallego issued the following press release: Today, Senator Ruben Gallego (D-AZ), one of the first two Colombian Americans ever elected to the U.S. Senate, spoke with ... Read More
WASHINGTON, Feb. 4 -- Sen. Alex Padilla issued the following press release: Today, U.S. Senator Alex Padilla (D-Calif.) announced that the Senate Committee on Energy and Natural Resources (ENR) advan... Read More
U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07385079) titled 'Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma' o... Read More
U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07383311) titled 'Autophagy-Enhancers to Reduce Sleep Disturbances' on Sept. 17, 2025. Brief Summary: This cl... Read More
U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07384611) titled 'Preoperative Prediction of Difficult Airway in Children' on Jan. 18. Brief Summary: This pr... Read More
U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07383935) titled 'Stress Ball Use During Chemotherapy in Gastrointestinal Cancer Patients' on Jan. 19. Brief ... Read More
U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07382739) titled 'A Phase 2 Study of Radiotherapy-induced Immune Priming to Enhance Elranatamab (Elra) in Rela... Read More